α-Ketoglutarate Alleviates the Pathogenesis of Systemic Lupus Erythematosus via Reducing Oxidative Stress and Attenuating Excessive Immune Response
- 1Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Guangzhou 511458, China
- 2Bioscience and Biomedical Engineering Thrust, Systems Hub, The Hong Kong University of Science and Technology (Guangzhou), Guangzhou 511453, China
- 3Department of Nutrition and Health, China Agricultural University, Beijing 100193, China
Abstract
Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease driven by dysregulated immune activation, with heterogeneous clinical manifestations and multi-organ injury. α-ketoglutarate (AKG) is a key intermediate metabolite of the tricarboxylic-acid cycle (TCA), participating in various physiological processes, including energy metabolism and immune regulation. Methods: In this study, 8-week-old female BALB/c mice were injected with pristane to establish an SLE mouse model. Using this model, we explored the therapeutic function and underlying mechanism of AKG intervention on SLE. Results: AKG administration significantly reduced serum antinuclear antibody (ANA) levels and alleviated renal injuries and biochemical improvement in SLE mice. Furthermore, it effectively maintained glomerular integrity and decreased the serum levels of biochemical enzymes and indices. Meanwhile, oxidative stress was ameliorated associated with the capacity of endogenous antioxidant enzymes and reducing the level of malondialdehyde (MDA). Most importantly, AKG upregulated the transcriptional levels of genes related to mitochondrial respiratory-chain complex, and increasing the production of adenosine triphosphate (ATP) in kidney tissues. Moreover, AKG administration regulated the proportion of spleen immune cells, and improved inflammation by decreasing the Interferon-stimulated genes (ISGs) expression levels, suppressing the liberation of inflammatory cytokines, ultimately alleviating SLE-associated damage. Conclusions: In summary, AKG protects against SLE through multi-targeted pathways, including suppressing oxidative stress, improving mitochondrial biogenesis-related factors, modulating immune-cell profiles, and dampening inflammatory response. These findings indicate that AKG has the effect of improving SLE.
Related
- Extract from Eucommia ulmoides Oliv. Leaves alleviates APAP-induced acute liver injury via reshaping gut microbiota and attenuating microbial bile acids metabolism disorder.
- Cyanidin-3-O-Glucoside in Anthocyanin-Rich Fraction Combined with Atorvastatin Mitigates Kidney Injury via Attenuating Renal Lipotoxicity and Oxidative Stress and Preserving Mitochondrial Function in Obese Rats
- Association between antinuclear antibodies, oxidative stress index, and immune markers in systemic lupus erythematosus
- Selective autophagy inhibition alleviates oxidative stress-associated neurodegeneration in an AD+CCH model
- The ferroptosis inhibitor NUPR1 coordinates the mitochondrial response to oxidative stress and cell metabolism during COPD pathogenesis in the lung
BibTeX
@article{ji2026αketoglutarate,
title = {{α-Ketoglutarate Alleviates the Pathogenesis of Systemic Lupus Erythematosus via Reducing Oxidative Stress and Attenuating Excessive Immune Response}},
author = {Yuting Ji and Jie Li and Zhiyao Zhao and Zhenglong Gu},
journal = {Nutrients},
year = {2026},
month = oct,
doi = {10.3390/nu18213600},
url = {https://www.mdpi.com/2072-6643/18/21/3600},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - α-Ketoglutarate Alleviates the Pathogenesis of Systemic Lupus Erythematosus via Reducing Oxidative Stress and Attenuating Excessive Immune Response
AU - Yuting Ji
AU - Jie Li
AU - Zhiyao Zhao
AU - Zhenglong Gu
PY - 2026
DA - 2026/10/30
JO - Nutrients
DO - 10.3390/nu18213600
UR - https://www.mdpi.com/2072-6643/18/21/3600
AB - Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease driven by dysregulated immune activation, with heterogeneous clinical manifestations and multi-organ injury. α-ketoglutarate (AKG) is a key intermediate metabolite of the tricarboxylic-acid cycle (TCA), participating in various physiological processes, including energy metabolism and immune regulation. Methods: In this study, 8-week-old female BALB/c mice were injected with pristane to establish an SLE mouse model. Using this model, we explored the therapeutic function and underlying mechanism of AKG intervention on SLE. Results: AKG administration significantly reduced serum antinuclear antibody (ANA) levels and alleviated renal injuries and biochemical improvement in SLE mice. Furthermore, it effectively maintained glomerular integrity and decreased the serum levels of biochemical enzymes and indices. Meanwhile, oxidative stress was ameliorated associated with the capacity of endogenous antioxidant enzymes and reducing the level of malondialdehyde (MDA). Most importantly, AKG upregulated the transcriptional levels of genes related to mitochondrial respiratory-chain complex, and increasing the production of adenosine triphosphate (ATP) in kidney tissues. Moreover, AKG administration regulated the proportion of spleen immune cells, and improved inflammation by decreasing the Interferon-stimulated genes (ISGs) expression levels, suppressing the liberation of inflammatory cytokines, ultimately alleviating SLE-associated damage. Conclusions: In summary, AKG protects against SLE through multi-targeted pathways, including suppressing oxidative stress, improving mitochondrial biogenesis-related factors, modulating immune-cell profiles, and dampening inflammatory response. These findings indicate that AKG has the effect of improving SLE.
SN - 2072-6643
ER -